Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hosotani

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Digestive Diseases and Sciences|January 24, 2009
Effect of synthetic porcine neuropeptide Y (NPY) on splanchnic blood flows and exocrine pancreatic secretion in dogsS Sumi, K Inoue, M Kogire, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Antiproliferative activity induced by the somatostatin analogue, TT-232, in human pancreatic cancer cellsJ-U Lee, R Hosotani, M Wada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Expression of METH-1 and METH-2 in pancreatic cancerT Masui, R Hosotani, S Tsuji, et al.
Biochemical and Biophysical Research Communications|October 26, 2001
A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesisM Kawaguchi, R Hosotani, S Ohishi, et al.
British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Digestive Diseases and Sciences|January 24, 2009
Effect of synthetic porcine neuropeptide Y (NPY) on splanchnic blood flows and exocrine pancreatic secretion in dogsS Sumi, K Inoue, M Kogire, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Antiproliferative activity induced by the somatostatin analogue, TT-232, in human pancreatic cancer cellsJ-U Lee, R Hosotani, M Wada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Expression of METH-1 and METH-2 in pancreatic cancerT Masui, R Hosotani, S Tsuji, et al.
Biochemical and Biophysical Research Communications|October 26, 2001
A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesisM Kawaguchi, R Hosotani, S Ohishi, et al.
British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.
Pageof 9